Understanding vaginal and rectal HIV transmission and protective cellular and molecular
mechanisms is critical for designing new prevention strategies, including those required for
an effective vaccine. The determinants of protection against HIV infection are, however,
poorly understood. Increasing evidence suggest that innate immune defenses may help
protect mucosal surfaces from HIV transmission in highly exposed, uninfected subjects.
More recent studies suggest that systemically administered type 1 interferon protects against …